DK1583967T3 - Fremgangsmåde til inhibering af replikationen af herpesvira - Google Patents

Fremgangsmåde til inhibering af replikationen af herpesvira

Info

Publication number
DK1583967T3
DK1583967T3 DK03795968T DK03795968T DK1583967T3 DK 1583967 T3 DK1583967 T3 DK 1583967T3 DK 03795968 T DK03795968 T DK 03795968T DK 03795968 T DK03795968 T DK 03795968T DK 1583967 T3 DK1583967 T3 DK 1583967T3
Authority
DK
Denmark
Prior art keywords
replication
inhibiting
herpes viruses
herpesviruses
methods
Prior art date
Application number
DK03795968T
Other languages
English (en)
Inventor
Ulrich Betz
Guy Hewlett
Gerald Kleymann
Thomas Lampe
Susanne Nikolic
Juergen Reefschlaeger
Tobias Wunberg
Holger Zimmermann
Kerstin Henninger
Axel Jensen
Joerg Keldenich
Rudolf Schohe-Loop
Tse-I Lin
Franz Zumpe
Wolfgang Bender
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Application granted granted Critical
Publication of DK1583967T3 publication Critical patent/DK1583967T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03795968T 2003-01-07 2003-12-24 Fremgangsmåde til inhibering af replikationen af herpesvira DK1583967T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10300109A DE10300109A1 (de) 2003-01-07 2003-01-07 Methode zur Inhibition der Replikation von Herpesviren
PCT/EP2003/014883 WO2004060860A2 (de) 2003-01-07 2003-12-24 Verfahren zur inhibierung der replikation von herpesviren

Publications (1)

Publication Number Publication Date
DK1583967T3 true DK1583967T3 (da) 2007-08-06

Family

ID=32519615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03795968T DK1583967T3 (da) 2003-01-07 2003-12-24 Fremgangsmåde til inhibering af replikationen af herpesvira

Country Status (9)

Country Link
US (1) US20070004735A1 (da)
EP (1) EP1583967B1 (da)
AT (1) ATE365920T1 (da)
AU (1) AU2003298244A1 (da)
DE (2) DE10300109A1 (da)
DK (1) DK1583967T3 (da)
ES (1) ES2286499T3 (da)
PT (1) PT1583967E (da)
WO (1) WO2004060860A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3440063B1 (en) 2016-04-06 2020-08-05 Innovative Molecules GmbH Aminothiazole derivatives useful as antiviral agents
CN111433203B (zh) 2017-10-05 2024-02-13 创新分子股份有限公司 作为抗病毒化合物的取代噻唑的对映异构体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659861B2 (en) * 1991-09-10 1995-06-01 Sansho Seiyaku Co., Ltd. Preparation for promoting hair growth
US6054472A (en) * 1996-04-23 2000-04-25 Vertex Pharmaceuticals, Incorporated Inhibitors of IMPDH enzyme
CA2223032A1 (en) * 1997-02-21 1998-08-21 Smithkline Beecham Corporation Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents
AU5556799A (en) * 1998-08-12 2000-03-06 University Of Virginia Patent Foundation Assay for assembly of herpes simplex virus capsid
US20010007877A1 (en) * 1998-12-16 2001-07-12 George O. Burton Novel anti-infectives
DE10148598A1 (de) * 2001-04-19 2002-10-24 Bayer Ag Neue Arylsulfonamide als antivirale Mittel
DE10131133A1 (de) * 2001-06-28 2003-01-16 Bayer Ag Pyridazinone
DE10222024A1 (de) * 2002-05-17 2003-11-27 Bayer Ag Lactame

Also Published As

Publication number Publication date
AU2003298244A1 (en) 2004-07-29
DE50307587D1 (de) 2007-08-09
DE10300109A1 (de) 2004-07-15
EP1583967B1 (de) 2007-06-27
ATE365920T1 (de) 2007-07-15
EP1583967A2 (de) 2005-10-12
ES2286499T3 (es) 2007-12-01
AU2003298244A8 (en) 2004-07-29
WO2004060860A3 (de) 2005-02-10
WO2004060860A2 (de) 2004-07-22
US20070004735A1 (en) 2007-01-04
PT1583967E (pt) 2007-07-13

Similar Documents

Publication Publication Date Title
DK1716162T3 (da) Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
BRPI0410870A (pt) compostos trieterocìclicos, composições, e métodos para tratar cáncer ou doenças virais
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
BRPI0411900B8 (pt) compostos e composições farmacêuticas compreendendo os mesmos
BRPI0507628A (pt) composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma infecção viral em um ser humano, uso de um composto composição farmacêutica, e, processo para a preparação de um composto
CR8778A (es) Revestimientos de azucar y metodos para estos
WO2008127364A3 (en) Antiviral compounds and use thereof
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
WO2004085479A3 (en) Treatment of viral infections
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
EA201200631A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20070751L (no) Inhibitorer av HCV-replifikasjon
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
BRPI0513513A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente
BRPI0514133A (pt) compostos de fórmula i, processo para a sua fabricação, composições farmacêuticas, método para o tratamento e/ou profilaxia de doença que são mediadas por inibidores de cetp e uso dos compostos de fórmula i
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
BRPI0416287A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização
RS51069B (sr) Upotreba oksikodona za tretiranje visceralnog bola
MX2009011512A (es) Nuevos compuestos peptidos ciclicos.
NO20091955L (no) Antivirale sammensetninger, og fremgangsmater for anvendelse
DK1853232T3 (da) Stabil krystallin form af bifeprunox mesylat, doseringsformer deraf og fremgangsmåder for deres anvendelse
WO2005041951A3 (en) Rhodanine derivatives for use as antiviral agents